ConductScience.org, home

Paper57118

Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.

Bech-Hansen NT and 2 others. J Cell Physiol, 1976. Cited by 319 papers, by iCite.

Cite this record

ConductScience Library. Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. Papers, record 57118. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/57118

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.
PubMed
Journal
J Cell Physiol
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
319
iCite
Relative citation ratio, by iCite
8.93
iCite
Revised in PubMed
2018-12-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bech-Hansen NTN T
2Till JEJ E
3Ling VV

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ColchicineMajor topic
Drug ResistanceMajor topic
Anesthetics, Local
Cell Line
Cell Membrane Permeability
Gramicidin
Mutation
Octanols
Phenotype
Polyethylene Glycols
Solubility
Steroids
Vinblastine

Source PubMed

Download CSV of topics

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 319 citations.

PMIDTitleJournalYearIn PapersSource
40723843Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives.Biomolecules2025https://conductscience.org/library/papers/40723843PubMed
36609245The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.BMC Cancer2023https://conductscience.org/library/papers/36609245PubMed
31406162Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells.Sci Rep2019https://conductscience.org/library/papers/31406162PubMed
24800945Uptake of compounds that selectively kill multidrug-resistant cells: the copper transporter SLC31A1 (CTR1) increases cellular accumulation of the thiosemicarbazone NSC73306.Mol Pharm2014https://conductscience.org/library/papers/24800945PubMed
24758331Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Chem Rev2014https://conductscience.org/library/papers/24758331PubMed
24492893Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?Drug Metab Dispos2014https://conductscience.org/library/papers/24492893PubMed
24478983Small and Innovative Molecules as New Strategy to Revert MDR.Front Oncol2014https://conductscience.org/library/papers/24478983PubMed
24305879MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.Cancer Res2014https://conductscience.org/library/papers/24305879PubMed
24177951Isolation and characterization of an uncoupler-resistant mutant of Saccharomyces cerevisiae.Curr Genet1984https://conductscience.org/library/papers/24177951PubMed
22676443Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.Mol Pharm2012https://conductscience.org/library/papers/22676443PubMed
22483810Collateral sensitivity as a strategy against cancer multidrug resistance.Drug Resist Updat2012https://conductscience.org/library/papers/22483810PubMed
20629994Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties.J Cell Mol Med2011https://conductscience.org/library/papers/20629994PubMed
19762091Is resistance useless? Multidrug resistance and collateral sensitivity.Trends Pharmacol Sci2009https://conductscience.org/library/papers/19762091PubMed
16862376Preface: the concept and consequences of multidrug resistance.Pflugers Arch2007https://conductscience.org/library/papers/16862376PubMed
11355953Effect of P-glycoprotein on flavopiridol sensitivity.Br J Cancer2001https://conductscience.org/library/papers/11355953PubMed
10704438In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity.J Cell Biol2000https://conductscience.org/library/papers/10704438PubMed
8824346Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro.Invest New Drugs1996https://conductscience.org/library/papers/8824346PubMed
8483936Functional replacement of the hemolysin A transport signal by a different primary sequence.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8483936PubMed
8369114Chemotherapeutic drug resistance in the management of head and neck cancer.Eur Arch Otorhinolaryngol1993https://conductscience.org/library/papers/8369114PubMed
8347489Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles.Br J Cancer1993https://conductscience.org/library/papers/8347489PubMed

See all 62 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/57118

GET https://conductscience.org/api/papers/v1/57118/cited_by?page=2